Wissenschaftliche Publikationen

JahrPublikation
2021 Cardoso R, Guo F, Heisser T, Hackl M, Ihle P, De Schutter H, Van Damme N, Valerianova Z, Atanasov T, Majek O, Muzik J, Nilbert MC, Tybjerg AJ, Innos K, Mägi M, Malila N, Bouvier AM, Bouvier V, Launoy G, Woronoff AS, Cariou M, Robaszkiewicz M, Delafosse P, Poncet F, Katalinic A, Walsh PM, Senore C, Rosso S, Vincerzevskiene I, Lemmens V, Elferink MAG, Johannesen TB, Korner H, Pfeffer F, Bento MJ, Rodrigues J, Alves da Costa F, Miranda A, Zadnik V, Zagar T, Lopez de Munain Marques A, Marcos-Gragera R, Puigdemont M, Galceran J, Carulla M, Chirlaque MD, Ballesta M, Sundquist K, Sundquist J, Weber M, Jordan A, Herrmann C, Mousavi M, Ryzhov A, Hoffmeister M, Brenner H. Colorectal cancer incidence, mortality, and stage distribution in European countries in the colorectal cancer screening era: an international population-based study. Lancet Oncol. 2021.
2021 Gieseler F, Heidenreich A, Schubert J, Frielitz F, Rehmann-Sutter C, Wörler F, Schües C, Hübner J, Elsner S, Block K, Rody A, von Bubnoff N, Keck T, Steimann M, Endsin G, Katalinic A. The role of family confidants and caregivers in the care of older cancer patients: Extending the concept of "shared decision-making". Health science reports. 2021;4(2):e281
2021 Hammersen F, Pursche T, Fischer D, Katalinic A, Waldmann A. Psychosocial and family-centered support among breast cancer patients with dependent children. Psychooncology. 2021;30(3):361-8.
2021 Krensel M, Petersen J, Stephan B, Katalinic A, Augustin J. Vergleich der Patientenpfade bei der Früherkennungsuntersuchung auf Hautkrebs – eine Sekundärdatenanalyse. J Dtsch Dermatol Ges. 2021;19(3):389-99
2021 Lillini R, Tittarelli A, Bertoldi M, Ritchie D, Katalinic A, Pritzkuleit R, Launoy G, Launay L, Guillaume E, Žagar T, Modonesi C, Meneghini E, Amati C, Di Salvo F, Contiero P, Borgini A, Baili P. Water and Soil Pollution: Ecological Environmental Study Methodologies Useful for Public Health Projects. A Literature Review. Reviews of environmental contamination and toxicology. 2021
2021 Pruessmann J, Pursche T, Hammersen F, Katalinic A, Fischer D, Waldmann A. Conditional Disease-Free and Overall Survival of 1,858 Young Women with Non-Metastatic Breast Cancer and with Participation in a Post-Therapeutic Rehab Programme according to Clinical Subtypes. Breast care (Basel, Switzerland). 2021;16(2):163-72
2021 Sacchetto L, Rosso S, Comber H, Bouchardy C, Broganelli P, Galceran J, Hackl M, Katalinic A, Louwman M, Robsahm TE, Tryggvadottir L, Tumino R, Van Eycken E, Walsh PM, Zadnik V, Zanetti R. Skin melanoma deaths within 1 or 3?years from diagnosis in Europe. Int J Cancer. 2021
2020 Arndt V, Holleczek B, Kajüter H, Luttmann S, Nennecke A, Zeissig SR, Kraywinkel K, Katalinic A. Data from Population-based Cancer Registration for Secondary Data Analysis: Methodological Challenges and Perspectives. Gesundheitswesen. 2020;82(S 01):62-71.
2020 Brunssen A, Jansen L, Eisemann N, Waldmann A, Weberpals J, Kraywinkel K, Eberle A, Holleczek B, Zeissig SR, Brenner H, Katalinic A. Long-term relative survival from melanoma in Germany 1997-2013. Melanoma Res. 2020;30(4):386-95.
2020 Hammersen F, Pursche T, Fischer D, Katalinic A, Waldmann A. Use of Complementary and Alternative Medicine among Young Patients with Breast Cancer. Breast Care. 2020;15(2):163-70.
2020 Hübner J, Katalinic A, Waldmann A, Kraywinkel K. Long-term Incidence and Mortality Trends for Breast Cancer in Germany. Geburtsh Frauenheilk. 2020;80(6):611-8.
2020 Jansen L, Holleczek B, Kraywinkel K, Weberpals J, Schröder CC, Eberle A, Emrich K, Kajüter H, Katalinic A, Kieschke J, Nennecke A, Sirri E, Heil J, Schneeweiss A, Brenner H. Divergent Patterns and Trends in Breast Cancer Incidence, Mortality and Survival Among Older Women in Germany and the United States. Cancers (Basel). 2020;12(9).
2020 Minicozzi P, Vicentini M, Innos K, Castro C, Guevara M, Stracci F, Carmona-Garcia M, Rodriguez-Barranco M, Vanschoenbeek K, Rapiti E, Katalinic A, Marcos-Gragera R, Van Eycken L, Sanchez MJ, Bielska-Lasota M, Rossi PG, Sant M. Comorbidities, timing of treatments, and chemotherapy use influence outcomes in stage III colon cancer: A population-based European study. Eur J Surg Oncol. 2020;46(6):1151-9.
2020 Sant M, Meneghini E, Bastos J, Rossi PG, Guevara M, Innos K, Katalinic A, Majuelo LG, Marcos-Gragera R, Molinié F, Rapiti E, Vizcaino A, Zadnik V, Minicozzi P. Endocrine treatment and incidence of relapse in women with oestrogen receptor-positive breast cancer in Europe: a population-based study. Breast Cancer Res Treat. 2020.
2020 Sirri E, Kieschke J, Vohmann C, Katalinic A, Nennecke A, Ressing M, Eberle A, Holleczek B, Jansen L, Brenner H. Survival of malignant mesothelioma and other rare thoracic cancers in Germany and the United States: A population-based study. Int J Cancer. 2020.
2019 Brunßen A, Eisemann N, Hübner J, Katalinic A. Aktuelle Evidenz zum Nutzen des Hautkrebs-Screenings. In: Günster C, Klauber J, Robra BP, Schmacke N, Schmucker C, editors. Versorgungs-Report Früherkennung. Berlin: MWV Medizinisch Wissenschaftliche Verlagsgesellschaft 2019. p. 191-207.
2019 Brunssen A, Jansen L, Eisemann N, Waldmann A, Weberpals J, Kraywinkel K, Eberle A, Holleczek B, Zeissig SR, Brenner H, Katalinic A. A population-based registry study on relative survival from melanoma in Germany stratified by tumor thickness for each histological subtype. J Am Acad Dermatol. 2019;80(4):938-46.
2019 Deck R, Babaev V, Katalinic A. [Reasons for the Non-Utilisation of an Oncological Rehabilitation. Results of a Written Survey with Patients of Oncological Healthcare Centers]. Reha. 2019;58(4):243-52.
2019 Garbe C, Keim U, Eigentler TK, Amaral T, Katalinic A, Holleczek B, Martus P, Leiter U. Time trends in incidence and mortality of cutaneous melanoma in Germany. Journal of the European Academy of Dermatology and Venereology : JEADV. 2019;33(7):1272-80.
2019 Gieseler F, Schäfer V, Rody A, Katalinic A, Maass N, Strohscheer I, Jürgensen M. Adherence of Older Breast Cancer Patients to Cancer Therapy Recommendations. Diversity and Equality in Health and Care. 2019;16(1):11-7.
2019 Hübner J, Hübner F, Terheyden P, Katalinic A. [Turning point in skin cancer mortality : An analysis of the trend in Germany from 1998 to 2017]. Hautarzt. 2019;70(12):989-92.
2019 Hübner J, Lewin P, Pritzkuleit R, Eisemann N, Maier W, Katalinic A. Colorectal cancer screening by colonoscopy and trends in disease-specific mortality: a population-based ecological study of 358 German districts. Int J Colorectal Dis. 2019;34(4):599-605.
2019 Katalinic A, Eisemann N, Kraywinkel K, Noftz MR, Hübner J. Breast cancer incidence and mortality before and after implementation of the German mammography screening program. Int J Cancer. 2019.
2019 Rudolph C, Petersen GS, Pritzkuleit R, Storm H, Katalinic A. The acceptance and applicability of a patient-reported experience measurement tool in oncological care: a descriptive feasibility study in northern Germany. BMC Health Serv Res. 2019;19(1):786.
2019 Rudolph CES, Katalinic A. [Baseline Incidence of HPV-Associated Invasive and in Situ Cancers in Germany Prior to Potential Vaccination Effects]. Gesundheitswesen. 2019;81:993-1000.
2018 Eisemann N, Waldmann A, Holleczek B, Katalinic A. Observed and expected mortality in the German skin cancer screening pilot project SCREEN. J Med Screen. 2018;25(3):166-8.
2018 Hübner J, Eisemann N, Brunßen A, Katalinic A. Hautkrebsscreening in Deutschland: Bilanz nach zehn Jahren. Bundesgesundheitsbl - Gesundheitsforsch - Gesundheitsschutz. 2018;61(12):1536-43.
2018 Hübner J, Waldmann A, Eisemann N, Noftz M, Geller AC, Weinstock MA, Volkmer B, Greinert R, Breitbart EW, Katalinic A. Association between risk factors and detection of cutaneous melanoma in the setting of a population-based skin cancer screening. Eur J Cancer Prev. 2018;27(6):563-9.
2018 Jansen L, Buttmann-Schweiger N, Listl S, Ressing M, Holleczek B, Katalinic A, Luttmann S, Kraywinkel K, Brenner H, Workgroup GCS. Differences in incidence and survival of oral cavity and pharyngeal cancers between Germany and the United States depend on the HPV-association of the cancer site. Oral oncology. 2018;76:8-15.
2018 Minicozzi P, Van Eycken L, Molinie F, Innos K, Guevara M, Marcos-Gragera R, Castro C, Rapiti E, Katalinic A, Torrella A, Zagar T, Bielska-Lasota M, Rossi PG, Larranaga N, Bastos J, Sanchez MJ, Sant M. Comorbidities, age and period of diagnosis influence treatment and outcomes in early breast cancer. Int J Cancer. 2018;144(9):2118-27.
2018 Pritzkuleit R, Katalinic A. Sozioökonomischer Status und Krebs. Public Health Forum. 2018;26(4):372-5.
2018 Pulte D, Weberpals J, Schroder CC, Emrich K, Holleczek B, Katalinic A, Luttmann S, Sirri E, Jansen L, Brenner H. Survival of patients with hepatobiliary tract and duodenal cancer sites in Germany and the United States in the early 21st century. Int J Cancer. 2018;143(2):324-32.
2018 Sacchetto L, Zanetti R, Comber H, Bouchardy C, Brewster DH, Broganelli P, Chirlaque MD, Coza D, Galceran J, Gavin A, Hackl M, Katalinic A, Laronningen S, Louwman MWJ, Morgan E, Robsahm TE, Sanchez MJ, Tryggvadottir L, Tumino R, Van Eycken E, Vernon S, Zadnik V, Rosso S. Trends in incidence of thick, thin and in situ melanoma in Europe. Eur J Cancer. 2018;92:108-18.
2018 Swetter SM, Geller AC, Leachman SA, Kirkwood JM, Katalinic A, Gershenwald JE. Melanoma Prevention and Screening. In: Balch C, al. e, editors. Cutaneous Melanoma. Cham: Springer; 2019.
2018 Wöckel A, Festl J, Stuber T, Brust K, Stangl S, Heuschmann PU, Albert US, Budach W, Follmann M, Janni W, Kopp I, Kreienberg R, Kuhn T, Langer T, Nothacker M, Scharl A, Schreer I, Link H, Engel J, Fehm T, Weis J, Welt A, Steckelberg A, Feyer P, Konig K, Hahne A, Kreipe HH, Knoefel WT, Denkinger M, Brucker S, Luftner D, Kubisch C, Gerlach C, Lebeau A, Siedentopf F, Petersen C, Bartsch HH, Schulz-Wendtland R, Hahn M, Hanf V, Muller-Schimpfle M, Henscher U, Roncarati R, Katalinic A, Heitmann C, Honegger C, Paradies K, Bjelic-Radisic V, Degenhardt F, Wenz F, Rick O, Holzel D, Zaiss M, Kemper G, Budach V, Denkert C, Gerber B, Tesch H, Hirsmuller S, Sinn HP, Dunst J, Munstedt K, Bick U, Fallenberg E, Tholen R, Hung R, Baumann F, Beckmann MW, Blohmer J, Fasching PA, Lux MP, Harbeck N, Hadji P, Hauner H, Heywang-Kobrunner S, Huober J, Hubner J, Jackisch C, Loibl S, Luck HJ, von Minckwitz G, Mobus V, Muller V, Nothlings U, Schmidt M, Schmutzler R, Schneeweiss A, Schutz F, Stickeler E, Thomssen C, Untch M, Wesselmann S, Bucker A, Krockenberger M. Interdisciplinary Screening, Diagnosis, Therapy and Follow-up of Breast Cancer. Guideline of the DGGG and the DKG (S3-Level, AWMF Registry Number 032/045OL, December 2017) - Part 1 with Recommendations for the Screening, Diagnosis and Therapy of Breast Cancer. Geburtshilfe Frauenheilkd. 2018;78(10):927-48.
2017 Brunssen A, Waldmann A, Eisemann N, Katalinic A. Impact of skin cancer screening and secondary prevention campaigns on skin cancer incidence and mortality: A systematic review. J Am Acad Dermatol. 2017;76(1):129-39 e10.
2017 Chen T, Brenner H, Fallah M, Jansen L, Castro FA, Geiss K, Holleczek B, Katalinic A, Luttmann S, Sundquist K, Ressing M, Xu L, Hemminki K. Risk of second primary cancers in women diagnosed with endometrial cancer in German and Swedish cancer registries. Int J Cancer. 2017;141(11):2270-80.
2017 Hager B, Kraywinkel K, Keck B, Katalinic A, Meyer M, Zeissig SR, Scheufele R, Wirth MP, Huber J. Increasing use of radical prostatectomy for locally advanced prostate cancer in the USA and Germany: a comparative population-based study. Prostate Cancer Prostatic Dis. 2017;20(1):61-6.
2017 Holleczek B, Katalinic A. Toward a comprehensive cancer registration in Germany. Eur J Cancer Prev. 2017;26:S132-S8.
2017 Hübner J, Waldmann A, Geller AC, Weinstock MA, Eisemann N, Noftz M, Bertram S, Nolte S, Volkmer B, Greinert R, Breitbart E, Katalinic A. Interval cancers after skin cancer screening: incidence, tumour characteristics and risk factors for cutaneous melanoma. Br J Cancer. 2017;116(2):253-9.
2017 Leiter U, Keim U, Eigentler T, Katalinic A, Holleczek B, Martus P, Garbe C. Incidence, Mortality and Trends of Non-Melanoma Skin Cancer in Germany. J Invest Dermatol. 2017;137(9):1860-7.
2017 Noftz MR, Hübner J, Katalinic A. Früherkennung bei Brustkrebs. Onkologe. 2017;5.
2017 Pritzkuleit R, Katalinic A, Gieseler F. Krebsregister und Gesundheitswesen. Anfragen bei Verdacht auf Krebshäufungen, Erwartungen und Befürchtungen. Onkologe. 2017;23(4).
2017 Pritzkuleit R, Katalinic A. Demografische Entwicklung. In: Willkomm M, editor. Praktische Geriatrie Klinik - Diagnostik - Interdisziplinäre Therapie 2, vollständig überarbeitete und erweiterte Auflage. Stuttgart - New York: Georg-Thieme-Verlag; 2017. p. 119-22.
2017 Pulte D, Weberpals J, Jansen L, Luttmann S, Holleczek B, Nennecke A, Ressing M, Katalinic A, Brenner H. Survival for patients with rare haematologic malignancies: Changes in the early 21st century. Eur J Cancer. 2017;84:81-7.
2017 Schmick A, Juergensen M, Rohde V, Katalinic A, Waldmann A. Assessing health-related quality of life in urology - a survey of 4500 German urologists. BMC Urol. 2017;17(1):46.
2017 Weberpals J, Pulte D, Jansen L, Luttmann S, Holleczek B, Nennecke A, Ressing M, Katalinic A, Merz M, Brenner H. Survival of patients with lymphoplasmacytic lymphoma and solitary plasmacytoma in Germany and the United States in the early 21st century. Haematologica. 2017;102(6):e229-e32.
2016 Brenner H, Castro FA, Eberle A, Emrich K, Holleczek B, Katalinic A, Jansen L, GEKID Cancer Survival Workgroup. Death certificate only proportions should be age adjusted in studies comparing cancer survival across populations and over time. Eur J Cancer. 2016;52:102-8.
2016 Brenner H, Schrotz-King P, Holleczek B, Katalinic A, Hoffmeister M. Declining Bowel Cancer Incidence and Mortality in Germany. Dtsch Ärztebl Int. 2016;113(7):101-6.
2016 Brunssen A, Hübner J, Katalinic A, Noftz M, Waldmann A. Breast Cancer Epidemiology. In: Jatoi I, Rody A, editors. Management of Breast Diseases 2. Aufl. ed. Schweiz: Springer Verlag; 2016. p. 125-37.
2016 Chen T, Fallah M, Brenner H, Jansen L, Mai EK, Castro FA, Katalinic A, Emrich K, Holleczek B, Geiss K, Eberle A, Sundquist K, Hemminki K, Gekid Cancer Survival Working Group. Risk of Second Primary Cancers in Multiple Myeloma Survivors in German and Swedish Cancer Registries. Sci Rep. 2016;6:22084.
2016 Eisemann N, Jansen L, Castro FA, Chen T, Eberle A, Nennecke A, Zeissig SR, Brenner H, Katalinic A, Group GCSW. Survival with nonmelanoma skin cancer in Germany. Br J Dermatol. 2016;174(4):778-85.
2016 Eisemann N, Schnoor M, Katalinic A. Prediction of chronic lymphocytic leukaemia incidence in Germany and of patients ineligible for standard chemotherapy. Hematol Oncol. 2016;34(2):93-101.
2016 Heywang-Kobrunner SH, Schreer I, Hacker A, Noftz MR, Katalinic A. Conclusions for mammography screening after 25-year follow-up of the Canadian National Breast Cancer Screening Study (CNBSS). Eur Radiol. 2016;26(2):342-50.
2016 Katalinic A. Improved prognosis for symptom-free older women with mammography-detected breast cancer? Strahlenther Onkol. 2016;192(2):130-2.
2016 Liu L, O'Donnell P, Sullivan R, Katalinic A, Moser L, de Boer A, Meunier F, Scientific, Organizing C. Cancer in Europe: Death sentence or life sentence? Eur J Cancer. 2016;65:150-5.
2016 Merz M, Jansen L, Castro FA, Hillengass J, Salwender H, Weisel K, Scheid C, Luttmann S, Emrich K, Holleczek B, Katalinic A, Nennecke A, Straka C, Langer C, Engelhardt M, Einsele H, Kröger N, Beelen D, Dreger P, Brenner H, Goldschmidt H, GEKID Cancer Survival Working Group and the DRST. Survival of elderly patients with multiple myeloma-Effect of upfront autologous stem cell transplantation. Eur J Cancer. 2016;62:1-8.
2016 Peller M, Katalinic A, Wollenberg B, Teudt IU, Meyer JE. Epidemiology of laryngeal carcinoma in Germany, 1998-2011. Eur Arch Otorhinolaryngol. 2016;273(6):1481-7.
2016 Pritzkuleit R, Katalinic A. Demografische Entwicklung und Krebsentwicklung in Deutschland. In: Keck T, Hopt UT, editors. Onkologische Chirurgie bei alten Patienten. Berlin, Heidelberg: Springer-Verlag; 2016. p. 3-11.
2016 Pritzkuleit R, Katalinic A. Epidemiologie von Krebs im jungen Erwachsenenalter. Forum. 2016.
2016 Pulte D, Castro FA, Jansen L, Luttmann S, Holleczek B, Nennecke A, Ressing M, Katalinic A, Brenner H, GEKID Cancer Survival Working Group. Trends in survival of chronic lymphocytic leukemia patients in Germany and the USA in the first decade of the twenty-first century. J Hematol Oncol. 2016;9(1):28.
2016 Pulte D, Jansen L, Castro FA, Krilaviciute A, Katalinic A, Barnes B, Ressing M, Holleczek B, Luttmann S, Brenner H, GEKID Cancer Survival Working Group. Survival in patients with acute myeloblastic leukemia in Germany and the United States: Major differences in survival in young adults. Int J Cancer. 2016;139(6):1289-96.
2016 Sirri E, Castro FA, Kieschke J, Jansen L, Emrich K, Gondos A, Holleczek B, Katalinic A, Urbschat I, Vohmann C, Brenner H. Recent Trends in Survival of Patients With Pancreatic Cancer in Germany and the United States. Pancreas. 2016;45(6):908-14.
2015 Castro FA, Jansen L, Krilaviciute A, Katalinic A, Pulte D, Sirri E, Ressing M, Holleczek B, Luttmann S, Brenner H, GEKID Cancer Survival Working Group. Survival of patients with gastric lymphoma in Germany and in the United States. J Gastroenterol Hepatol. 2015;30(10):1485-91.
2015 Chen T, Fallah M, Jansen L, Castro FA, Krilavicuite A, Katalinic A, Eisemann N, Emrich K, Holleczek B, Geiss K, Eberle A, Sundquist J, Brenner H, Hemminki K, Group GCSW. Distribution and risk of the second discordant primary cancers combined after a specific first primary cancer in German and Swedish cancer registries. Cancer letters. 2015;369(1):152-66.
2015 Deck R, Walther AL, Staupendahl A, Katalinic A. [Limitations of Social Participation in General Population - Normative Data of the IMET based on a Population-Based Survey in Northern Germany]. Reha. 2015;54(6):402-8.
2015 Eberle A, Jansen L, Castro F, Krilaviciute A, Luttmann S, Emrich K, Holleczek B, Nennecke A, Katalinic A, Brenner H, Group GSW. Lung cancer survival in Germany: A population-based analysis of 132,612 lung cancer patients. Lung cancer. 2015;90(3):528-33.
2015 Eisemann N, Nolte S, Schnoor M, Katalinic A, Rohde V, Waldmann A. The ProCaSP study: quality of life outcomes of prostate cancer patients after radiotherapy or radical prostatectomy in a cohort study. BMC Urol. 2015;15:28.
2015 Eisemann N, Schnoor M, Katalinic A. Prediction of chronic lymphocytic leukaemia incidence in Germany and of patients ineligible for standard chemotherapy. Hematol Oncol. 2015.
2015 Eisemann N, Waldmann A, Garbe C, Katalinic A. Development of a microsimulation of melanoma mortality for evaluating the effectiveness of population-based skin cancer screening. Med Decis Making. 2015;35(2):243-54.
2015 Fick EM, Katalinic A, Waldmann A. The Frequency of and Risk Factors for the Use of Bisphosphonates in the Adjuvant Setting of Primary Breast Cancer in Germany. Cancer Research and Treatment. 2015;47(4):747-56.
2015 Gebauer J, Fick EM, Waldmann A, Langer T, Kreitschmann-Andermahr I, Lehnert H, Katalinic A, Brabant G. Self-reported endocrine late effects in adults treated for brain tumours, Hodgkin and non-Hodgkin lymphoma - a registry based study in Northern Germany. Eur J Endocrinol. 2015;173(2):139-48.
2015 Hager B, Kraywinkel K, Keck B, Katalinic A, Meyer M, Zeissig SR, Stabenow R, Froehner M, Huber J. Integrated prostate cancer centers might cause an overutilization of radiotherapy for low-risk prostate cancer: A comparison of treatment trends in the United States and Germany from 2004 to 2011. Radiother Oncol. 2015.
2015 Haug U, Katalinic A. Familiäres Kolonkarzinomrisiko – überschätzt oder real? Gastroenterologe. 2015;10(1):17-20.
2015 Haug U, Rosch T, Hoffmeister M, Katalinic A, Brenner H, Becker N. [Implementing an Organised Colorectal Cancer Screening Programme in Germany: Opportunities and Challenges]. Gesundheitswesen. 2015;77(11):869-74.
2015 Jansen L, Castro FA, Gondos A, Krilaviciute A, Barnes B, Eberle A, Emrich K, Hentschel S, Holleczek B, Katalinic A, Brenner H, GEKID Cancer Survival Working Group. Recent cancer survival in Germany: an analysis of common and less common cancers. Int J Cancer. 2015;136(11):2649-58.
2015 Katalinic A, Eisemann N, Waldmann A. Hautkrebsscreening in Deutschland. Dtsch Ärztebl. 2015;112(38):629-34.
2015 Katalinic A, Eisemann N, Waldmann A. Skin Cancer Screening in Germany. Documenting Melanoma Incidence and Mortality From 2008 to 2013. Dtsch Ärztebl Int. 2015;112(38):629-34.
2015 Katalinic A, Fauteck H. QuaMaDi: Eine Erfolgsbilanz. Nordlicht aktuell. 2015;18(6):16-7.
2015 Katalinic A. Krebsfrüherkennung - Sinn oder Unsinn? Oncol Res Treat. 2015;38(Suppl 3):12.
2015 Peters E, Anzeneder T, Jackisch C, Dimpfl T, Kunz G, Katalinic A, Waldmann A. The Treatment of Primary Breast Cancer in Older Women With Adjuvant Therapy: A Retrospective Analysis of Data From Over 3000 Patients From the PATH Biobank, With Two-Year Follow-up. Dtsch Ärztebl Int. 2015;112(35-36):577-84.
2015 Peters E, Anzeneder T, Jackisch C, Dimpfl T, Kunz G, Katalinic A, Waldmann A. Versorgung primärer Mammakarzinome bei älteren Frauen mit adjuvanter Therapie. Dtsch Ärztebl. 2015;112(35-36):577-84.
2015 Pulte D, Jansen L, Castro FA, Emrich K, Katalinic A, Holleczek B, Brenner H, GEKID Cancer Survival Working Group. Trends in survival of multiple myeloma patients in Germany and the United States in the first decade of the 21st century. Br J Haematol. 2015.
2015 Rudolph C, Schnoor M, Eisemann N, Katalinic A. Incidence trends of nonmelanoma skin cancer in Germany from 1998 to 2010. J Dtsch Dermatol Ges. 2015;13(8):788-97.
2015 Sant M, Chirlaque Lopez MD, Agresti R, Sanchez Perez MJ, Holleczek B, Bielska-Lasota M, Dimitrova N, Innos K, Katalinic A, Langseth H, Larranaga N, Rossi S, Siesling S, Minicozzi P, Group E-W. Survival of women with cancers of breast and genital organs in Europe 1999-2007: results of the EUROCARE-5 study. Eur J Cancer. 2015.
2015 Storm HH, Engholm G, Pritzkuleit R, Kejs AM, Katalinic A, Dunst J, Hollander NH. Less pitfalls and variation in population based cancer survival comparisons within the European Union: Lessons from colorectal cancer patients in neighbouring regions in Denmark and Germany - The Fehmarn Belt project. Eur J Cancer. 2015;51(9):1188-98.
2014 Breitbart EW, Choudhury K, Anders MP, Volkmer B, Greinert R, Katalinic A, Tacke J, Keilholz U. Benefits and risks of skin cancer screening. Oncol Res Treat. 2014;37(Suppl 3):38-47.
2014 Eisemann N, Waldmann A, Geller AC, Weinstock MA, Volkmer B, Greinert R, Breitbart EW, Katalinic A. Non-melanoma skin cancer incidence and impact of skin cancer screening on incidence. J Invest Dermatol. 2014;134(1):8.
2014 Eisemann N, Waldmann A, Katalinic A. Inzidenz des malignen Melanoms und Veränderung der stadienspezifischen Inzidenz nach Einführung eines Hautkrebsscreenings in Schleswig-Holstein. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2014;57(1):7.
2014 Eisemann N, Waldmann A, Rohde V, Katalinic A. Quality of life in partners of patients with localised prostate cancer. Qual Life Res. 2014;23(5):1557-68.
2014 Haug U, Rösch T, Hoffmeister M, Katalinic A, Brenner H, Becker N. Implementing an Organised Colorectal Cancer Screening Programme in Germany: Opportunities and Challenges. Gesundheitswesen. 2014.
2014 Hübner J, Noftz MR, Schnoor M, Katalinic A. Screening for colorectal, skin, breast and prostate cancer. Essential knowledge for counseling. Internist (Berl). 2014;55(10):1171-81.
2014 Jansen L, Eberle A, Emrich K, Gondos A, Holleczek B, Kajüter H, Maier W, Nennecke A, Pritzkuleit R, Brenner H, GEKID Cancer Survival Working Group. Socioeconomic deprivation and cancer survival in Germany: an ecological analysis in 200 districts in Germany. Int J Cancer. 2014;134(12):2951-60.
2014 Kapsimalakou S, Waldmann A, Katalinic A, Grande-Nagel I, Fischer D, Barkhausen J, Vogt FM. Follow-up of probably benign lesions in non-screening breast diagnostics. Arch Gynecol Obstet. 2014;290(3):543-51.
2014 Katalinic A, Waldmann A, Augustin M, Breitbart E, Eisemann N. Evidenz für ein Hautkrebsscreening. Onkologe. 2014;20(6):535-42.
2014 Pulte D, Jansen L, Gondos A, Emrich K, Holleczek B, Katalinic A, Brenner H, GEKID Cancer Survival Working Group. Improved population level survival in younger Hodgkin lymphoma patients in Germany in the early 21st century. Br J Haematol. 2014;164(6):851-7.
2014 Pulte D, Jansen L, Gondos A, Katalinic A, Barnes B, Ressing M, Holleczek B, Eberle A, Brenner H, GEKID Cancer Survival Working Group. Survival of adults with acute lymphoblastic leukemia in Germany and the United States. PLoS One. 2014;9(1):e85554.
2014 Stabenow R, Katalinic A, Wilsdorf-Köhler H. Stärkung der Zusammenarbeit klinischer und epidemiologischer Krebsregister. Forum. 2014;29(1):7.
2014 Storm HH, Engholm G, Pritzkuleit R, Kejs AM, Katalinic A, Dunst J, Holländer NH. Less pitfalls and variation in population based cancer survival comparisons within the European Union: Lessons from colorectal cancer patients in neighbouring regions in Denmark and Germany - The Fehmarn Belt project. Eur J Cancer. 2014.
2013 Eisemann N, Waldmann A, Katalinic A. Epidemiology of Breast Cancer – Current Figures and Trends. Geburtsh Frauenheilk. 2013;73(2):130–5.
2013 Fick E-M, Anzeneder T, Katalinic A, Waldmann A. Bisphosphonate und ihre Rolle in der Therapie des Mammakarzinoms – Ergebnisse aus der Biobank PATH. Senologie. 2013;10(4):236-45.
2013 Greiner F, Nolte S, Waldmann A, Katalinic A, Breitbart EW. Erfassung und Verarbeitung von persönlichen Daten zur Evaluation von Krebsfrüherkennungsprogrammen – Ergebnisse einer Bevölkerungsbefragung im Kontext des Krebsfrüherkennungs- und -registergesetzes. Gesundheitswesen. 2013;75(11):751-3.
2013 Katalinic A, Richter A, Babaev V, Pritzkuleit R. Krebsregistrierung im europäischen und nichteuropäischen Ausland. Was können wir lernen? Onkologe. 2013;19:1025–36
2013 Listl S, Jansen L, Stenzinger A, Freier K, Emrich K, Holleczek B, Katalinic A, Gondos A, Brenner H, GEKID Cancer Survival Working Group. Survival of patients with oral cavity cancer in Germany. PLoS One. 2013;8(1):e53415.
2013 Liu H, Hemminki K, Sundquist J, Holleczek B, Katalinic A, Emrich K, Jansen L, Brenner H, GEKID Cancer Survival Working Group. A population-based comparison of second primary cancers in Germany and Sweden between 1997 and 2006: clinical implications and etiologic aspects. Cancer Med. 2013;2(5):718-24.
2013 Majek O, Gondos A, Jansen L, Emrich K, Holleczek B, Katalinic A, Nennecke A, Eberle A, Brenner H, GEKID Cancer Survival Working Group. Sex differences in colorectal cancer survival: population-based analysis of 164,996 colorectal cancer patients in Germany. PLoS One. 2013;8(7):e68077.
2013 Pritzkuleit R, Fauteck H, Katalinic A. Epidemiologische Grundlagen der Onkologie. best practice onkologie. 2013;8(2):6-14.
2013 Rusner C, Trabert B, Katalinic A, Kieschke J, Emrich K, Stang A, Network of German Cancer Registries (GEKID). Incidence patterns and trends of malignant gonadal and extragonadal germ cell tumors in Germany, 1998-2008. Cancer Epidemiol. 2013;37(4):370-3.
2013 Schnoor M, Hallof A, Hergert-Lüder D, Katalinic A, Waldmann A. Gründe für die Nicht-Teilnahme am Mammographie-Screening – eine Querschnittsuntersuchung aus Schleswig-Holstein. Dtsch Med Wochenschr. 2013;138(45):2289-94.
2013 Stang A, Jansen L, Trabert B, Rusner C, Eberle A, Katalinic A, Emrich K, Holleczek B, Brenner H, GEKID Cancer Survival Working Group. Survival after a diagnosis of testicular germ cell cancers in Germany and the United States, 2002-2006: a high resolution study by histology and age. Cancer Epidemiol. 2013;37(4):492-7.
2013 Waldmann A, Anzeneder T, Katalinic A. Patients and Methods of the PATH Biobank – A Resource for Breast Cancer Research. Geburtshilfe Frauenheilkd. 2014;74(4):361-9.
2013 Waldmann A, Eisemann N, Katalinic A. Epidemiology of Malignant Cervical, Corpus Uteri and Ovarian Tumours – Current Data and Epidemiological Trends. Geburtsh Frauenheilk. 2013;73(2):123–9.
2013 Waldmann A, Schubert D, Katalinic A. Normative data of the EORTC qlq-c30 for the german population: a population-based survey. PLoS One. 2013;8(9):e74149.
2013 Zanetti R, Sacchetto L, Calvia M, Bordoni A, Hakulinen T, Znaor A, Møller H, Siesling S, Comber H, Katalinic A, Rosso S, Eurocourse WP3 Working Group. Economic evaluation of cancer registration in Europe. J Registry Manag. 2014;41(1):31-7.
2012 Breitbart EW, Waldmann A, Nolte S, Capellaro M, Greinert R, Volkmer B, Katalinic A. Systematic skin cancer screening in Northern Germany. J Am Acad Dermatol. 2012;66(2):201-11.
2012 Chen T, Jansen L, Gondos A, Emrich K, Holleczek B, Katalinic A, Luttmann S, Meyer M, Brenner H. Survival of ovarian cancer patients in Germany in the early 21st century: a period analysis by age, histology, laterality, and stage. Eur J Cancer Prev. 2012;22(1):9.
2012 Chen T, Jansen L, Gondos A, Ressing M, Holleczek B, Katalinic A, Brenner H. Survival of endometrial cancer patients in Germany in the early 21st century: a period analysis by age, histology, and stage. BMC Cancer. 2012;12(1):128.
2012 Eisemann N, Jansen L, Holleczek B, Waldmann A, Luttmann S, Emrich K, Hauschild A, Brenner H, Katalinic A, GEKID Survival Working Group. Up-to-date results on survival of patients with melanoma in Germany. Br J Dermatol. 2012;167(3):7.
2012 Hertrampf K, Wiltfang J, Katalinic A, Timm O, Wenz HJ. Recent trends in incidence and mortality of oral and pharyngeal cancer in Schleswig-Holstein in Northern Germany. Community Dent Health. 2012;29(4):6.
2012 Hiripi E, Jansen L, Gondos A, Emrich K, Holleczek B, Katalinic A, Luttmann S, Nennecke A, Brenner H. Survival of stomach and esophagus cancer patients in Germany in the early 21st century. Acta Oncol. 2012;51:9.
2012 Jansen L, Gondos A, Eberle A, Emrich K, Holleczek B, Katalinic A, Brenner H. Cancer survival in Eastern and Western Germany after the fall of the iron curtain. Eur J Epidemiol. 2012;27(9):5.
2012 Katalinic A, Waldmann A, Weinstock MA, Geller AC, Eisemann N, Greinert R, Volkmer B, Breitbart E. Does Skin Cancer Screening Save Lives? - An Observational Study Comparing Trends in Melanoma Mortality in Regions With and Without Screening. Cancer. 2012;118(21):8.
2012 Katalinic A, Waldmann A. Brustkrebs sicher und früh diagnostiziert – fast immer geheilt? Geburtsh Frauenheilk. 2012;72:3.
2012 Kraywinkel K, Wolf U, Katalinic A. Hautkrebs - Epidemiologie und Früherkennung. 2. ed. Bundesamt für Strahlenschutz (BfS) BfRB, Robert Koch-Institut (RKI), Umweltbundesamt (UBA), editor. Berlin: Umweltbundesamt; 2012. 30-4 p.
2012 Liu H, Hemminki K, Sundquist J, Holleczek B, Katalinic A, Emrich K, Brenner H, Group GCSW. Second primary cancers after cancer of unknown primary in Sweden and Germany: efficacy of the modern work-up. Eur J Cancer Prev. 2012;22(3):5.
2012 Majek O, Gondos A, Jansen L, Emrich K, Holleczek B, Katalinic A, Nennecke A, Eberle A, Brenner H. Survival from colorectal cancer in Germany in the early 21st century. Br J Cancer. 2012;106:6.
2012 Perl M, Waldmann A, Pritzkuleit R, Katalinic A. Zeitlicher Verlauf der Lebensqualität nach Prostatakarzinom [Temporal changes in quality of life after prostate carcinoma]. Urologe. 2012;5(5):7.
2012 Pulte D, Jansen L, Gondos A, Emrich K, Holleczek B, Katalinic A, Brenner H, the GCSWG. Survival of non-Hodgkin lymphoma patients in Germany in the early 21st century Leukemia & lymphoma. 2012;54(5):7.
2012 Rusner C, Bandemer-Greulich U, Engel J, Stegmaier C, Zawinell A, Holleczek B, Katalinic A, Kuss O, Schmidt-Pokrzywniak A, Schubert-Fritschle G, Tillack A, Stang A. Population-based hormone receptor-specific incidence trends of breast cancer in Germany. Maturitas. 2012;73(2):6.
2012 Schnoor M, Waldmann A, Eberle A, Holleczek B, Katalinic A. Colorectal cancer incidence in Germany: Stage-shift 6 years after implementation of a colonoscopy screening program. Cancer Epidemiol. 2012;36:4.
2012 Siewert U, Hoffmann W, Fendrich K, Katalinic A, Pritzkuleit R. Demographische Herausforderung und Zukunft der onkologischen Versorgung. Onkologe. 2012;18(2):11.
2012 Waldmann A, Adrich S, Eisemann N, Fauteck H, Grande-Nagel I, Schaefer FK, Vorkefeld M, Warnecke C, Weidner K, Wilke C, Katalinic A. [Structure and process quality of quality-assured mamma diagnostics in Schleswig-Holstein]. Röfo. 2012;184(2):113-21.
2012 Waldmann A, Kapsimalakou S, Katalinic A, Grande-Nagel I, Stoeckelhuber BM, Fischer D, Barkhausen J, Vogt FM. Benefits of the quality assured double and arbitration reading of mammograms in the early diagnosis of breast cancer in symptomatic women. Eur Radiol. 2012;22(5):9.
2012 Waldmann A, Nolte S, Geller AC, Katalinic A, Weinstock MA, Volkmer B, Greinert R, Breitbart EW. Frequency of excisions and yields of malignant skin tumors in a population-based screening intervention of 360,288 whole-body examinations. Arch Dermatol. 2012;148(8):8.
2012 Waldmann A, Nolte S, Weinstock MA, Breitbart EW, Eisemann N, Geller AC, Greinert R, Volkmer B, Katalinic A. Skin cancer screening participation and impact on melanoma incidence in Germany--an observational study on incidence trends in regions with and without population-based screening. Br J Cancer. 2012;106(5):5.
2011 Brenner H, Altenhofen L, Katalinic A, Lansdorp-Vogelaar I, Hoffmeister M. Sojourn Time of Preclinical Colorectal Cancer by Sex and Age: Estimates From the German National Screening Colonoscopy Database. Am J Epidemiol. 2011.
2011 Dittmer C, Katalinic A, Mundhenke C, Thill M, Fischer D. Epidemiology of vulvar and vaginal cancer in Germany. Arch Gynecol Obstet. 2011;284(1):169-74.
2011 Eisemann N, Waldmann A, Katalinic A. Imputation of missing values of tumour stage in population-based cancer registration. BMC Med Res Methodol. 2011;11:129.
2011 Geller AC, Greinert R, Sinclair C, Weinstock MA, Aitken J, Boniol M, Capellaro M, Dore JF, Elwood M, Fletcher SW, Gallagher R, Gandini S, Halpern AC, Katalinic A, Lucas R, Marghoob AA, Nolte S, Schuz J, Tucker MA, Volkmer B, Breitbart E. A nationwide population-based skin cancer screening in Germany: Proceedings of the first meeting of the International Task Force on Skin Cancer Screening and Prevention (September 24 and 25, 2009). Cancer Epidemiol. 2010;34(3):355-8.
2011 Hakulinen T, Arbyn M, Brewster DH, Coebergh JW, Coleman MP, Crocetti E, Forman D, Gissler M, Katalinic A, Luostarinen T, Pukkala E, Rahu M, Storm H, Sund R, Tornberg S, Tryggvadottir L. Harmonization may be counterproductive--at least for parts of Europe where public health research operates effectively. Eur J Public Health. 2011;21(6):686-7.
2011 Hentschel S, Pritzkuleit R, Schmid-Höpfner S, Katalinic A. Epidemiologische Krebsregistrierung in Deutschland. Aufgaben und aktueller Status. Onkologe. 2011;17(2).
2011 Hertrampf K, Wiltfang J, Katalinic A, Timm O, Wenz HJ. Trends in incidence, tumour sites and tumour stages of oral and pharyngeal cancer in Northern Germany. J Cancer Res Clin Oncol. 2011.
2011 Hiripi E, Gondos A, Emrich K, Holleczek B, Katalinic A, Luttmann S, Sirri E, Brenner H. Survival from common and rare cancers in Germany in the early 21st century. Ann Oncol. 2011.
2011 Obi N, Waldmann A, Schafer F, Schreer I, Katalinic A. Impact of the Quality assured Mamma Diagnostic (QuaMaDi) programme on survival of breast cancer patients. Cancer Epidemiol. 2011;35(3):286-92.
2011 Waldmann A, Knese M, Küchler T, Katalinic A, Rohde V. PORPUS: Ein kurzer, alltagstauglicher und valider Lebensqualitätsfragebogen zur Erfassung prostataspezifischer Symptome. Journal für Urologie und Urogynäkologie. 2011;18(3):5-10.
2011 Waldmann A, Nolte S, Pritzkuleit R, Breitbart EW, Katalinic A. Different Aspects of Self-Reported Quality of Life in 450 German Melanoma Survivors. Cancers. 2011;3(2):2316-32.
2010 Katalinic A, Emrich K, Luttmann S, Holleczek B, Stabenow R, Urbschat I, Meyer M. Häufigkeiten, Trends und regionale Unterschiede von Krebserkrankungen in Deutschland. Prävention. 2010;33(4):99-102.
2010 Katalinic A, Peters E, Beske F, Pritzkuleit R. Projection of Morbidity 2030 and 2050: Impact for the National Health System and Blood Supply. Transfus Med Hemother. 2010;37(3):155-9.
2010 Peters E, Pritzkuleit R, Beske F, Katalinic A. Demografischer Wandel und Krankheitshäufigkeiten. Eine Projektion bis 2050. Bundesgesundheitsbl. 2010;53(5):417-26.
2010 Pritzkuleit R, Beske F, Katalinic A. Demographischer Wandel und Krebserkrankungen in der Zukunft. Onkologie. 2010;33 (Suppl 7):19-24.
2010 Schaefer FK, Waldmann A, Katalinic A, Wefelnberg C, Heller M, Jonat W, Schreer I. Influence of additional breast ultrasound on cancer detection in a cohort study for quality assurance in breast diagnosis-analysis of 102,577 diagnostic procedures. Eur Radiol. 2010;20(5):1085-92.
2010 Stang A, Katalinic A, Dieckmann KP, Pritzkuleit R, Stabenow R. A novel approach to estimate the German-wide incidence of testicular cancer. Cancer Epidemiol. 2010;34(1):13-9.
2010 Waldmann A, Dreckschmidt J, Pritzkuleit R, Katalinic A. Test-Retest Reliabilität des OVIS-Fragebogens - Ein Instrument zur Evaluation der onkologischen Versorgung aus Patientensicht. Gesundheitswesen. 2010;72:707-13.
2009 Katalinic A, Lemmer A, Zawinell A, Rawal R, Waldmann A. Trends in hormone therapy and breast cancer incidence - Results from the German Network of Cancer Registries. Pathobiology. 2009;76(2):90-7.
2009 Katalinic A, Pritzkuleit R, Waldmann A. Recent Trends in Breast Cancer Incidence and Mortality in Germany. Breast Care. 2009;4:75-80.
2009 Katalinic A, Raspe H, Waldmann A. Identifikation von Personen mit familiärem oder hereditärem Darmkrebsrisiko mittels eines Fragebogens zur Familienanamnese. Z Gastroenterol. 2009;47:1125-31.
2009 Pritzkuleit R, Katalinic A. Räumliche Karzinomanalyse: regionaler Vergleich der Inzidenz kolorektaler Karzinome in Bayern im Zeitraum 2006-2008. Lübeck: Institut für Krebsepidemiologie; 2009.
2009 Schafmayer C, Buch S, Völzke H, von Schonfels W, Egberts JH, Schniewind B, Brosch M, Ruether A, Franke A, Mathiak M, Sipos B, Henopp T, Catalcali J, Hellmig S, ElSharawy A, Katalinic A, Lerch MM, John U, Fölsch UR, Fändrich F, Kalthoff H, Schreiber S, Krawczak M, Tepel J, Hampe J. Investigation of the colorectal cancer susceptibility region on chromosome 8q24.21 in a large German case-control sample. Int J Cancer. 2009;124(1):75-80.
2009 Waldmann A, Eberle A, Hentschel S, Holleczek B, Katalinic A. Bevölkerungsbezogene Darmkrebsinzidenz im Zeitraum 2000 bis 2006 - Deuten sich erste Auswirkungen des Koloskopie-Screenings an? Eine gemeinsame Auswertung der Krebsregisterdaten aus Bremen, Hamburg, dem Saarland und Schleswig-Holstein
2009 Waldmann A, Raspe H, Katalinic A. Darmkrebsrisiko bei familiären und hereditären Risikopersonen unter 55 Jahren. Z Gastroenterol. 2009;47:1052-8.
2009 Waldmann A, Rohde V, Bremner K, Krahn M, Küchler T, Katalinic A. Measuring prostate-specific quality of life in prostate cancer patients scheduled for radiotherapy or radical prostatectomy and reverence men in Germany and Canada using the Patient Oriented Prostate Utility Scale-Psychometric (PORPUS-P). BMC Cancer. 2009;9.
2008 Heywang-Köbrunner SH, Schreer I, Heindel W, Katalinic A. Bildgebung für die Brustkrebsfrüherkennung. Dtsch Ärztebl. 2008;105(31-32):541-7.
2008 Hüppe D, Hartmann H, Felten G, Kemen M, Tannapfel A, Gillessen A, Katalinic A. Die Vorsorgekoloskopie rettet Leben--Ergebnisse der Herner Vorsorgedatei. Z Gastroenterol. 2008;46(2):193-200.
2008 Katalinic A, Rawal R. Decline in breast cancer incidence after decrease in utilisation of hormone replacement therapy. Breast Cancer Res Treat. 2008;107(3):427-30.
2008 Pritzkuleit R, Waldmann A, Raspe H, Katalinic A. The population-based oncological health care study OVIS - Recruitment of the patients and analysis of the non-participants. BMC Cancer. 2008;8(1):311-23.
2008 Waldmann A, Pritzkuleit R, Raspe H, Katalinic A. S3-Leitlinien-gerechte Versorgung von Patientinnen mit Mammakarzinom. Aktueller Stand in Schleswig-Holstein. Dtsch Ärztebl. 2008;105(18):337-43.
2007 Katalinic A, Bartel C, Raspe H, Schreer I. Beyond mammography screening: quality assurance in breast cancer diagnosis (The QuaMaDi Project). Br J Cancer 2007; 96(1):157-161.
2007 Katalinic A, Rawal R. Decline in breast cancer incidence after decrease in utilisation of hormone replacement therapy. Breast Cancer Res Treat 2007.
2007 Schafmayer C, Buch S, Egberts JH, Franke A, Brosch M, El SA, Conring M, Koschnick M, Schwiedernoch S, Katalinic A, Kremer B, Folsch UR, Krawczak M, Fandrich F, Schreiber S, Tepel J, Hampe J. Genetic investigation of DNA-repair pathway genes PMS2, MLH1, MSH2, MSH6, MUTYH, OGG1 and MTH1 in sporadic colon cancer. Int J Cancer 2007.
2007 Waldmann A, Lautz E, Hampe J, Schreiber S, Schafmayer C, Raspe H, Katalinic A. [Description of the medical care of younger patients (<65 years) with colorectal cancer in Schleswig-Holstein--are diagnostics and therapy compliant with the actual S3-guidelines?]. Gesundheitswesen 2007; 69(4):216-223.
2007 Waldmann A, Pritzkuleit R, Raspe H, Katalinic A. The OVIS study: health related quality of life measured by the EORTC QLQ-C30 and -BR23 in German female patients with breast cancer from Schleswig-Holstein. Qual Life Res 2007; 16(5):767-776.
2006 Rohde V, Diemer T, Hauck E, Bestmann B, Miller J, Schroder H, Weidner W, Katalinic A. Prescription practice for LH-RH analogs and androgen receptor antagonists in the treatment of advanced prostate cancer in Germany (1993-2003). Urol Int 2006; 77(4):311-316.
2005 Lehnert M, Eberle A, Hentschel S, Katalinic A, Kieschke J, Schmidtmann I, Schubert-Fritschle G, Stegmaier C, Hense HW. [Malignant melanoma of the skin as evidenced by epidemiological cancer registries in Germany -- incidence, clinical parameters, variations in recording]. Gesundheitswesen 2005; 67(10):729-735.
2005 Stang A, Streller B, Katalinic A, Lehnert M, Eisinger B, Kaatsch P, Jockel KH. Incidence of Skin Lymphoma in Germany. Ann Epidemiol 2005.
2004 Gierspien K, Haartje U, Hentschel S, Katalinic A, Kieschke J. Tumorstadienverteilung in der Zielgruppe für das Mammographie-Screening. Deutsches Ärzteblatt 2004; 101(30):2117-2122.
2004 Katalinic A. Epidemiologische Krebsregistrierung in Deutschland - Bestandsaufnahme und Perspektiven. Bundesgesundheitsbl 2004; 47(5):422-428.
2003 Katalinic A, Holzmann M, Kunze U. Abhängigkeit der Tumorstadien von der Vollzähligkeit der Registrierung bei Brustkrebs in einem bevölkerungsbezogenen Krebsregister. Gesundheitswesen 2003; 65(8-9):509-515.
2003 Katalinic A, Kunze U, Schäfer T. Epidemiology of cutaneous melanoma and non melanoma skin cancer in Schleswig-Holstein, Germany: incidence, clinical subtypes, tumour stages and localization (Epidemiology of skin cancer). BJD 2003;(149):1200-1206.
Menü